Nibblen Life Sciences Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Nibblen Life Sciences Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $2.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Nibblen Life Sciences Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $2.1M Trade | TransData Nexus

Nibblen Life Sciences Private Limited

Indian Pharmaceutical Exporter · Nutritional Supplements Specialist · $2.1M Total Trade · DGFT Verified

Nibblen Life Sciences Private Limited is an Indian pharmaceutical exporter with a total trade value of $2.1M across 3 products in 1 therapeutic categories. Based on 64 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Vitamin ($1.4M), Glucosamine ($631.3K), Chondroitin ($81.7K).

Nibblen Life Sciences Private Limited — Export Portfolio & Destination Treemap

Nibblen Life Sciences Private Limited pharmaceutical export portfolio — 3 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Nibblen Life Sciences Private Limited? — Company Overview & Market Position

Nibblen Life Sciences Private Limited is an Indian pharmaceutical exporter established on December 1, 2017, in Saidapet, Tamil Nadu. The company is registered under the Corporate Identification Number (CIN) U74999TN2017PTC119781. It operates as a private limited company with an authorized capital of ₹2.5 million and a paid-up capital of ₹0.5 million. The registered office is located at Plot No. 29 & 30, 4th Floor, Ramalingam Nagar Main Road, Sabthagiri Nagar, Puzhuthivakkam, Saidapet, Tamil Nadu, 600091.

As of the financial year ending March 31, 2024, Nibblen Life Sciences reported a total revenue of ₹25.16 million, with a net worth of ₹25.16 million. The company has experienced a 7.25% decrease in revenue and a 48.76% decrease in profit compared to the previous year. The company is led by directors Krishnamurthy Premalatha, Kuppuswamy Sabitha, Venugopal Venkata Subramanyam, and Pasupathy Krishnamoorthy.

What Does Nibblen Life Sciences Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Vitamin$1.4M 2

Product Portfolio — Top 3 by Export Value

Nibblen Life Sciences Private Limited exports 3 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Vitamin	Nutritional Supplements	$1.4M	27	0.9%	4
2	Glucosamine	Nutritional Supplements	$631.3K	34	4.8%	7
3	Chondroitin	Nutritional Supplements	$81.7K	3	1.6%	13

Nibblen Life Sciences Private Limited exports 3 pharmaceutical products across 1 therapeutic categories with a total export value of $2.1M. The top category is Nutritional Supplements (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Nibblen Life Sciences Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Nibblen Life Sciences Private Limited operates manufacturing facilities in Saidapet, Tamil Nadu. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding plant capacities and additional specializations are not publicly disclosed.

3Key Leadership

The leadership team of Nibblen Life Sciences Private Limited comprises four directors:

Krishnamurthy Premalatha
Kuppuswamy Sabitha
Venugopal Venkata Subramanyam
Pasupathy Krishnamoorthy

All directors were appointed on December 1, 2017. Detailed information regarding their individual roles and professional backgrounds is not publicly available.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Nibblen Life Sciences Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Nibblen Life Sciences Private Limited's export data indicates shipments to various international markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's total export value is $2.1 million, with 64 shipments across three products in the nutritional supplements category. The top three products exported are Vitamin ($1.4 million), Glucosamine ($631,000), and Chondroitin ($82,000). However, specific details regarding regulatory filings, approvals, and market access status in these regions are not publicly disclosed.

2Emerging Markets

Nibblen Life Sciences Private Limited's export data does not provide specific information regarding its presence in emerging markets such as Africa, Latin America, and Southeast Asia. Additionally, there is no publicly available information about the company's WHO prequalification status, which would enable access to these markets.

3Geographic Strategy

The company's export data indicates a focus on the nutritional supplements category, with a portfolio concentration of 100% in this segment. The top three products exported are Vitamin, Glucosamine, and Chondroitin, suggesting a strategic emphasis on these products. However, specific details regarding the company's geographic diversification, concentration risk, and strategic direction are not publicly available.

Nibblen Life Sciences Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

There is no publicly available information regarding Nibblen Life Sciences Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history.

2WHO & EU GMP

The company's export data does not provide information regarding WHO prequalification or EU Good Manufacturing Practice (GMP) certifications. Specific details about the company's compliance with these standards are not publicly disclosed.

3CDSCO & Indian Regulatory

Nibblen Life Sciences Private Limited's export data does not include information about its compliance with the Central Drugs Standard Control Organisation (CDSCO) regulations, state drug controller approvals, or export No Objection Certificates (NOCs). Specific details regarding the company's adherence to Indian regulatory requirements are not publicly available.

Recent Regulatory Actions

Nibblen Life Sciences Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

The company's export data indicates a focus on the nutritional supplements category, with a portfolio concentration of 100% in this segment. The top three products exported are Vitamin, Glucosamine, and Chondroitin, suggesting a strategic emphasis on these products. However, specific details regarding the company's competitors in overlapping categories, market share comparisons, and head-to-head analyses are not publicly available.

2Key Differentiators

Nibblen Life Sciences Private Limited's export data indicates a focus on the nutritional supplements category, with a portfolio concentration of 100% in this segment. The top three products exported are Vitamin, Glucosamine, and Chondroitin, suggesting a strategic emphasis on these products. However, specific details regarding the company's unique strengths, competitive advantages, and product portfolio distinctions are not publicly available.

3Strategic Position

The company's export data indicates a focus on the nutritional supplements category, with a portfolio concentration of 100% in this segment. The top three products exported are Vitamin, Glucosamine, and Chondroitin, suggesting a strategic emphasis on these products. However, specific details regarding the company's current strategic direction, such as a focus on generics, specialty drugs, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services, as well as its future outlook, are not publicly available.

Buyer Due Diligence Brief — Evaluating Nibblen Life Sciences Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Nibblen Life Sciences Private Limited's export data indicates a total export value of $2.1 million across 64 shipments, with a portfolio concentration of 100% in the nutritional supplements category. The top three products exported are Vitamin, Glucosamine, and Chondroitin. However, specific details regarding the company's overall track record, export volume consistency, and reliability indicators are not publicly available.

2Certifications to Verify

Importers should verify the following certifications when considering Nibblen Life Sciences Private Limited as a supplier:

FDA Registration: Confirm the company's registration status with the U.S. Food and Drug Administration (FDA).
WHO-GMP Certification: Verify the company's compliance with World Health Organization Good Manufacturing Practice (GMP) standards.
EU GMP Certification: Ensure the company holds European Union GMP certification.

Frequently Asked Questions — Nibblen Life Sciences Private Limited

How many pharmaceutical products does Nibblen Life Sciences Private Limited export from India?

Nibblen Life Sciences Private Limited exports 3 pharmaceutical products across 1 therapeutic categories. The top exports are Vitamin ($1.4M), Glucosamine ($631.3K), Chondroitin ($81.7K). Total export value is $2.1M.

What is Nibblen Life Sciences Private Limited's total pharmaceutical export value?

Nibblen Life Sciences Private Limited's total pharmaceutical export value is $2.1M, based on 64 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Nibblen Life Sciences Private Limited cover?

Nibblen Life Sciences Private Limited exports across 1 therapeutic categories. The largest are Nutritional Supplements (100.0%, 3 products).

Get Full Nibblen Life Sciences Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.